InvestorsObserver
×
News Home

Is Vera Therapeutics Inc (VERA) a Bad Choice in Biotechnology Wednesday?

Wednesday, March 27, 2024 11:54 AM | InvestorsObserver Analysts

Mentioned in this article

Is Vera Therapeutics Inc (VERA) a Bad Choice in Biotechnology Wednesday?

Vera Therapeutics Inc (VERA) is near the top in its industry group according to InvestorsObserver. VERA gets an overall rating of 68. That means it scores higher than 68 percent of stocks. Vera Therapeutics Inc gets a 82 rank in the Biotechnology industry. Biotechnology is number 20 out of 148 industries.

Overall Score - 68
VERA has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on VERA!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 68 means the stock is more attractive than 68 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Vera Therapeutics Inc Stock Today?

Vera Therapeutics Inc (VERA) stock is trading at $42.27 as of 11:42 AM on Wednesday, Mar 27, a gain of $0.69, or 1.66% from the previous closing price of $41.58. The stock has traded between $41.31 and $42.50 so far today. Volume today is less active than usual. So far 90,544 shares have traded compared to average volume of 914,641 shares. Click Here to get the full Stock Report for Vera Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App